Solara Active Pharma Sciences Ltd Share Price
As of 23 Sept 2026, Solara Active Pharma Sciences Ltd share price is ₹725.30. The stock opened at ₹725.30 and had closed at ₹744.90 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹422.85 and a high of ₹774.00. In terms of performance, Solara Active Pharma Sciences Ltd share price has increased by 69.30% over the past six months and has increased by 15.61% over the last year.
SOLARA Stock Price Chart
Solara Active Pharma Sciences Ltd Overview
About SOLARA
Solara Active Pharma Sciences is undertaking the business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients.
Solara Active Pharma Sciences Ltd Historical Performance
Solara Active Pharma Sciences Ltd Fundamentals
Solara Active Pharma Sciences Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 1,374.87 | 1,292.90 | 1,294.29 | 1,465.95 | 1,287.10 |
| EBITDA | 186.68 | 212.98 | -279.33 | 156.18 | 95.62 |
| Net Profit | -7.24 | -1.08 | -566.87 | -22.21 | -58.56 |
| EPS | -1.64 | -0.27 | -157.48 | -6.17 | -16.29 |
Solara Active Pharma Sciences Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 737.58 |
| Resistance 1 (R1) | 754.63 |
| Pivot Point | 747.32 |
Solara Active Pharma Sciences Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 18-Aug-2021 | 06-May-2021 | 20-Aug-2021 | Final | ₹3.00 |
SOLARA Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| RAJAGOPALAN RAMAKRISHNAN | Chairman |
| Kausalya Santhanam | Non Executive Independent Director |
| Rajendra Kumar Srivastava | Non Executive Independent Director |
Solara Active Pharma Sciences Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,860.70+0.77% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,495.00+1.53% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,967.00+0.65% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Solara Active Pharma Sciences Ltd today is ₹725.30 on NSE and ₹725.30 on BSE.
- The 52-week high of Solara Active Pharma Sciences Ltd is ₹774.00, while the 52-week low is ₹422.85.
- The current market capitalisation of Solara Active Pharma Sciences Ltd is approximately ₹3,615 crore.
- The P/E (Price-to-Earnings) ratio of Solara Active Pharma Sciences Ltd is -87.27. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Solara Active Pharma Sciences Ltd is 1.34. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Solara Active Pharma Sciences Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for SOLARA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Solara Active Pharma Sciences Ltd has delivered a return of approximately 130.76%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Solara Active Pharma Sciences Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 41.93% promoters, 10.57% FIIs, 3.74% DIIs, and 25.84% public shareholders.

